Parametric Portfolio Associates’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.45M | Buy |
48,564
+31,546
| +185% | +$854K | ﹤0.01% | 2591 |
|
|
2021
Q4 | $451K | Sell |
17,018
-5,592
| -25% | -$169K | ﹤0.01% | 3112 |
|
|
2021
Q3 | $821K | Sell |
22,610
-1,318
| -6% | -$51.9K | ﹤0.01% | 2887 |
|
|
2021
Q2 | $1.04M | Buy |
23,928
+1,188
| +5% | +$44.9K | ﹤0.01% | 2751 |
|
|
2021
Q1 | $778K | Buy |
22,740
+11,658
| +105% | +$462K | ﹤0.01% | 3277 |
|
|
2020
Q4 | $388K | Buy |
11,082
+496
| +5% | +$14.4K | ﹤0.01% | 3489 |
|
|
2020
Q3 | $254K | Sell |
10,586
-1,031
| -9% | -$25.3K | ﹤0.01% | 3557 |
|
|
2020
Q2 | $213K | Buy |
11,617
+2,830
| +32% | +$50.9K | ﹤0.01% | 3610 |
|
|
2020
Q1 | $137K | Sell |
8,787
-12,646
| -59% | -$269K | ﹤0.01% | 3657 |
|
|
2019
Q4 | $459K | Buy |
21,433
+3,974
| +23% | +$81.8K | ﹤0.01% | 3399 |
|
|
2019
Q3 | $326K | Buy |
17,459
+934
| +6% | +$19.3K | ﹤0.01% | 3497 |
|
|
2019
Q2 | $431K | Buy |
16,525
+14,851
| +887% | +$335K | ﹤0.01% | 3420 |
|
|
2019
Q1 | $43K | Sell |
1,674
-689
| -29% | -$15.8K | ﹤0.01% | 3892 |
|
|
2018
Q4 | $54K | Sell |
2,363
-4,032
| -63% | -$114K | ﹤0.01% | 3845 |
|
|
2018
Q3 | $205K | Sell |
6,395
-650
| -9% | -$19.5K | ﹤0.01% | 3753 |
|
|
2018
Q2 | $199K | Buy |
7,045
+4,058
| +136% | +$144K | ﹤0.01% | 3701 |
|
|
2018
Q1 | $106K | Buy |
2,987
+743
| +33% | +$29.7K | ﹤0.01% | 3850 |
|
|
2017
Q4 | $87K | Sell |
2,244
-251
| -10% | -$9.55K | ﹤0.01% | 3842 |
|
|
2017
Q3 | $63K | Sell |
2,495
-478
| -16% | -$11.6K | ﹤0.01% | 3981 |
|
|
2017
Q2 | $81K | Sell |
2,973
-109
| -4% | -$2.98K | ﹤0.01% | 3939 |
|
|
2017
Q1 | $102K | Buy |
3,082
+312
| +11% | +$7.95K | ﹤0.01% | 3693 |
|
|
2016
Q4 | $66K | Sell |
2,770
-6,376
| -70% | -$183K | ﹤0.01% | 3729 |
|
|
2016
Q3 | $336K | Sell |
9,146
-3,761
| -29% | -$108K | ﹤0.01% | 3365 |
|
|
2016
Q2 | $288K | Buy |
12,907
+330
| +3% | +$8.21K | ﹤0.01% | 3466 |
|
|
2016
Q1 | $262K | Sell |
12,577
-373
| -3% | -$9.2K | ﹤0.01% | 3652 |
|
|
2015
Q4 | $392K | Buy |
12,950
+489
| +4% | +$14.8K | ﹤0.01% | 3411 |
|
|
2015
Q3 | $308K | Buy |
12,461
+4,088
| +49% | +$122K | ﹤0.01% | 2949 |
|
|
2015
Q2 | $269K | Buy |
8,373
+1,009
| +14% | +$38.5K | ﹤0.01% | 3634 |
|
|
2015
Q1 | $263K | Buy |
7,364
+308
| +4% | +$8.45K | ﹤0.01% | 3623 |
|
|
2014
Q4 | $160K | Buy |
7,056
+2,584
| +58% | +$52.3K | ﹤0.01% | 3837 |
|
|
2014
Q3 | $87K | Sell |
4,472
-2,705
| -38% | -$76.4K | ﹤0.01% | 3736 |
|
|
2014
Q2 | $261K | Sell |
7,177
-1,458
| -17% | -$49.6K | ﹤0.01% | 3602 |
|
|
2014
Q1 | $335K | Buy |
8,635
+887
| +11% | +$31.6K | ﹤0.01% | 3384 |
|
|
2013
Q4 | $221K | Buy |
7,748
+3,780
| +95% | +$111K | ﹤0.01% | 3572 |
|
|
2013
Q3 | $142K | Buy |
+3,968
| New | +$145K | ﹤0.01% | 3677 |
|
Other funds holding RIGL
RSCM
N
GPP
